Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Oncoimmunology|February 9, 2018
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancerFlorian Posch, Karina Silina, Sebastian Leibl, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysisJakob M Riedl, Florian Posch, Lena Horvath, et al.
Pharmacogenetics and Genomics|September 10, 2014
Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patientsYu Sunakawa, Takeru Wakatsuki, Dongyun Yang, et al.
International Journal of Molecular Sciences|October 17, 2018
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor PatientsAngelika Terbuch, Jan B Adiprasito, Verena Stiegelbauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal CarcinogenesisMartin Pichler, Verena Stiegelbauer, Petra Vychytilova-Faltejskova, et al.
Iscience|October 27, 2025
Evaluation of urinary cfDNA workflows for the molecular profiling of malignant diseaseAnna Eberhard, Tina Moser, Leandra Ziegler, et al.
JACC. Cardiooncology|January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint InhibitorsFlorian Moik, Jakob M Riedl, Dominik Barth, et al.
British Journal of Cancer|June 15, 2021
T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological studyMaria A Smolle, Laurin Herbsthofer, Barbara Granegger, et al.
Scientific Reports|July 10, 2020
Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapyMarie-Christin Klöckl, Anne-Katrin Kasparek, Jakob M Riedl, et al.
Anticancer Research|October 3, 2022
Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRCArmin Gerger, Wolfgang Eisterer, Stefan Fuxius, et al.
Pageof 16